Why should the clonogenic cell assay be prognostically important in ovarian cancer?
Cannistra
S A
SA
D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000473:pathology*; D011379:Prognosis; D014410:Tumor Stem Cell Assay / Q000379:methods*